%0 Journal Article
%T Mono- and dual-targeting triplebodies activate natural killer cells and have anti-tumor activity in vitro and in vivo against chronic lymphocytic leukemia
%A Ann-Charlott Schneider
%A Elke Pogge von Strandmann
%A Hinrich P. Hansen
%A Katrin S. Reiners
%A Maulik Vyas
%A Michael Hallek
%A Olga Shatnyeva
%A Samir Tawadros
%A Stephan Kloess
%A Ulrike K£¿hl
%J Archive of "Oncoimmunology".
%D 2016
%R 10.1080/2162402X.2016.1211220
%K CLL
%K CD19
%K immunoligand
%K NK cells
%K NKG2D
%K triplebody
%K ULBP2
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049355/